Literature DB >> 23607756

Ipilimumab in pretreated metastastic uveal melanoma patients. Results of the Dutch Working group on Immunotherapy of Oncology (WIN-O).

Sander Kelderman1, Monique K van der Kooij, Alfons J M van den Eertwegh, Patricia M M B Soetekouw, Rob L H Jansen, Rob R H van den Brom, Geke A P Hospers, John B A G Haanen, Ellen Kapiteijn, Christian U Blank.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23607756     DOI： 10.3109/0284186X.2013.786839

Source DB:  PubMed          Journal:  Acta Oncol        ISSN： 0284-186X            Impact factor:   4.089


× No keyword cloud information.
  30 in total

Review 1.  Latest developments in the biology and management of uveal melanoma.

Authors:  Sapna P Patel
Journal:  Curr Oncol Rep       Date:  2013-12       Impact factor: 5.075

Review 2.  Uveal melanoma as a target for immune-therapy.

Authors:  Marc Oliva; Antonio J Rullan; Josep M Piulats
Journal:  Ann Transl Med       Date:  2016-05

3.  Are PD-1 antibodies safe for use in metastatic uveal melanoma?

Authors:  Katy K Tsai; Alain P Algazi
Journal:  Melanoma Manag       Date:  2017-05-10

Review 4.  Immunotherapy for uveal melanoma.

Authors:  Dae Won Kim; Jaime Anderson; Sapna P Patel
Journal:  Melanoma Manag       Date:  2016-05-19

Review 5.  Immunotherapy for the Treatment of Uveal Melanoma: Current Status and Emerging Therapies.

Authors:  Kimberly M Komatsubara; Richard D Carvajal
Journal:  Curr Oncol Rep       Date:  2017-07       Impact factor: 5.075

Review 6.  Biology of advanced uveal melanoma and next steps for clinical therapeutics.

Authors:  Jason J Luke; Pierre L Triozzi; Kyle C McKenna; Erwin G Van Meir; Jeffrey E Gershenwald; Boris C Bastian; J Silvio Gutkind; Anne M Bowcock; Howard Z Streicher; Poulam M Patel; Takami Sato; Jeffery A Sossman; Mario Sznol; Jack Welch; Magdalena Thurin; Sara Selig; Keith T Flaherty; Richard D Carvajal
Journal:  Pigment Cell Melanoma Res       Date:  2014-09-01       Impact factor: 4.693

Review 7.  Adjuvant Therapy of Uveal Melanoma: Current Status.

Authors:  Pierre L Triozzi; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2014-09-10

8.  Management of uveal melanoma: a consensus-based provincial clinical practice guideline.

Authors:  E Weis; T G Salopek; J G McKinnon; M P Larocque; C Temple-Oberle; T Cheng; J McWhae; R Sloboda; M Shea-Budgell
Journal:  Curr Oncol       Date:  2016-02-18       Impact factor: 3.677

9.  Treatment of metastatic uveal melanoma with adoptive transfer of tumour-infiltrating lymphocytes: a single-centre, two-stage, single-arm, phase 2 study.

Authors:  Smita S Chandran; Robert P T Somerville; James C Yang; Richard M Sherry; Christopher A Klebanoff; Stephanie L Goff; John R Wunderlich; David N Danforth; Daniel Zlott; Biman C Paria; Arvind C Sabesan; Abhishek K Srivastava; Liqiang Xi; Trinh H Pham; Mark Raffeld; Donald E White; Mary Ann Toomey; Steven A Rosenberg; Udai S Kammula
Journal:  Lancet Oncol       Date:  2017-04-07       Impact factor: 41.316

Review 10.  Uveal melanoma: From diagnosis to treatment and the science in between.

Authors:  Chandrani Chattopadhyay; Dae Won Kim; Dan S Gombos; Junna Oba; Yong Qin; Michelle D Williams; Bita Esmaeli; Elizabeth A Grimm; Jennifer A Wargo; Scott E Woodman; Sapna P Patel
Journal:  Cancer       Date:  2016-03-15       Impact factor: 6.860
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.